Company Overview
Snapshot
Founded in October 2020 by Moshe Ashkenazi, Ori Efrati, and Gil Sokol, Synchrony Medical operates with 1–10 employees. The company has raised $6.8M across 3 funding rounds. In February 2026, Synchrony Medical secured $5M in funding to support the commercial expansion of its at-home airway clearance device for chronic respiratory disease.
Business overview
Synchrony Medical is a clinical-stage medical device company that develops LibAirty, a next-generation airway clearance system designed for home use. This technology aims to help patients with chronic lung diseases, such as chronic obstructive pulmonary disease and cystic fibrosis, maintain clear lungs through short and effective daily treatments. The company operates within the Health Tech & Life Sciences sector, focusing on medical devices, digital healthcare, and patient remote monitoring.
Strategic signal
In October 2025, Synchrony Medical launched its LibAirty Airway Clearance System in the US market. This launch signifies a critical step in the company's commercialization strategy, indicating market readiness and a move towards broader adoption of its at-home respiratory care solution. For investors, this signals strong progress in bringing its medical device to patients and establishing a new standard for respiratory care.
Log in to access full profile ›Company Intelligence Q&A
- What is Synchrony Medical's core product?
- Synchrony Medical's core product is LibAirty, a next-generation airway clearance system designed for home use by patients with chronic lung diseases.
- When did Synchrony Medical launch LibAirty in the US?
- Synchrony Medical launched its LibAirty Airway Clearance System in the US in October 2025, aiming to set a new standard for at-home respiratory care.
- Has Synchrony Medical's LibAirty system received regulatory approval?
- In July 2025, Synchrony Medical received FDA approval for its LibAirty technology for clearing airways.
- What was a significant funding event for Synchrony Medical?
- In February 2026, Synchrony Medical secured $5M in funding, led by.
- What were the findings of a clinical study on LibAirty?
- A clinical study conducted at the Medical University of South Carolina in October 2023 found Synchrony Medical's LibAirty Airway Clearance System to be highly effective for chronic lung disease patients.